EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists

Sharanappa Gurikar, Syed Sagheer Ahmed, Bharathi Doddlu Raghunatahanaidu

Journal of Molecular Neuroscience · 15.10.2025 · 75 (4)

DOI: 10.1007/s12031-025-02433-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 15.10.2025. Verfasst von Sharanappa Gurikar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Mandya, Karnata…. Hauptthemen laut MEDLINE: Alzheimer Disease, Oligodendroglia, Drug Repositioning, Serotonin Receptor Agonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 162 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseOligodendrogliaDrug RepositioningSerotonin Receptor AgonistsHistamine AntagonistsHumansAnimals

Stichwörter der Autor:innen

5-HT agonistsAntihistaminesDrug repurposingNeurodegenerationOligodendrocyte

Substanzen

Serotonin Receptor AgonistsHistamine Antagonists

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Mandya, Karnataka, India, 571448.
  • Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Mandya, Karnataka, India, 571448. sagheer@accp.co.in.

Zitieren

APA

Gurikar, S., Ahmed, S. S., & Raghunatahanaidu, B. D. (2025). Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists. Journal of Molecular Neuroscience, 75(4). https://doi.org/10.1007/s12031-025-02433-5

Vancouver

Gurikar S, Ahmed SS, Raghunatahanaidu BD. Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists. Journal of Molecular Neuroscience. 2025;75(4). doi:10.1007/s12031-025-02433-5

BibTeX
@article{Gurikar2025,
  author = {Gurikar, Sharanappa and Ahmed, Syed Sagheer and Raghunatahanaidu, Bharathi Doddlu},
  title = {Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists},
  journal = {Journal of Molecular Neuroscience},
  year = {2025},
  volume = {75},
  number = {4},
  doi = {10.1007/s12031-025-02433-5}
}
Kostenlos starten →